Presbia To Participate In The Rodman & Renshaw 18th Annual Healthcare Conference

DUBLIN--(BUSINESS WIRE)--Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens™, a propriety optical lens implant for treating the age-related loss of near-vision, announced that Jarett Fenton, CFO of Presbia, is scheduled to present at the Rodman & Renshaw 18^th Annual Healthcare Conference being held September 11^th through 13^th at the Lotte New York Palace Hotel in New York City. Mr. Fenton will be available for one-on-one meetings at the conference.

“The Rodman & Renshaw Conference will provide the investor community with an increased awareness of our solution for near-vision loss”

“The Rodman & Renshaw Conference will provide the investor community with an increased awareness of our solution for near-vision loss,” said Todd Cooper, President and CEO of Presbia. “We look forward to showcasing our results as the best surgical treatment for presbyopia, as well as discuss our commercial expansion strategy into South Korea which has the highest LASIK penetration in the world.”

Details of the presentation are as follows:

Date: Monday, September 12, 2016
Time: 2:10 PM ET
Room: Kennedy I (4th Floor)

About Presbia

Presbia PLC (NASDAQ:LENS) is an ophthalmic device company that has developed and is currently marketing the presbyopia-correcting Presbia Flexivue Microlens™, a miniature lens that is implanted in a corneal pocket created by a femtosecond laser. The Presbia Flexivue Microlens has received a CE mark for the European Economic Area, allowing the lens to be marketed in over 30 countries across Europe. A staged pivotal U.S. clinical trial for the Presbia Flexivue Microlens commenced in 2014.

Forward-Looking Statements

Information provided and statements contained in this press release that are not purely historical are forward-looking statements. Such forward-looking statements only speak as of the date of this press release and Presbia assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although Presbia believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, Presbia also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.